Interestingly, expression of CTAG1B/A and PRAME has recently been correlated with tumor grade and poor prognosis in myxoid sarcomas, supporting our hypothesis that CTAG1B/A is active in sarcoma biology (Iura et al., 2015). This evidence concerns the gene PRAME and sarcoma.